Neuroendocrine Cancer Treatments and Advances in Radioligand Therapy

  Рет қаралды 736

Neuroendocrine Cancer UK

Neuroendocrine Cancer UK

Жыл бұрын

As part of the Neuroendocrine Cancer UK Virtual Summit 2020, Dr Amy Eccles speaks about the spectrum of treatments for Neuroendocrine Cancer as well as advances & options in Radioligland Therapy.

Пікірлер: 1
@DCGreenZone
@DCGreenZone 5 ай бұрын
>>Undetectable levels of Prostate Specific Antigen (PSA) have been reported from the first patient with metastatic castrate-resistant prostate cancer (mCRPC) to ever receive two cycles of Clarity’s 67Cu-SAR-bisPSMA at the 8GBq dose level. PSA is a marker of tumour burden, clinical response to treatment and an indicator of the recurrence of disease for prostate cancer.
Professor Nick Reed - Q&A Session - High Grade Neuroendocrine Cancer
34:28
Neuroendocrine Cancer UK
Рет қаралды 879
Heartwarming Unity at School Event #shorts
00:19
Fabiosa Stories
Рет қаралды 23 МЛН
What it feels like cleaning up after a toddler.
00:40
Daniel LaBelle
Рет қаралды 82 МЛН
Little girl's dream of a giant teddy bear is about to come true #shorts
00:32
PSMA Scans & Pluvicto (lutetium-177) in 2022 | Geoffrey Johnson, MD, PhD | PCRI Conference 2022
1:10:05
The Doctor's Experience of Living with Neuroendocrine Cancer
19:15
Neuroendocrine Cancer UK
Рет қаралды 604
CAR T-cell Therapy: The Good, The Bad and The Long-Term 2022
59:12
Carcinoid Syndrome - causes, symptoms, diagnosis, treatment, pathology
7:14
Osmosis from Elsevier
Рет қаралды 99 М.
Dr John Ayuk - Q&A Session - Hormones
15:48
Neuroendocrine Cancer UK
Рет қаралды 274
New Standards of Care for Advanced Prostate Cancer
19:50
Grand Rounds in Urology
Рет қаралды 9 М.
Heartwarming Unity at School Event #shorts
00:19
Fabiosa Stories
Рет қаралды 23 МЛН